Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2025 Jun;49(6):1406-1417.
doi: 10.1002/wjs.12589. Epub 2025 Apr 19.

Comparison of Clinicopathologic Features and Survival Outcomes of Pleomorphic Lobular, Classical Lobular, and Invasive Ductal Carcinoma

Ahmet Necati Sanli  1 , Halil Kara  2 , Deniz Esin Tekcan Sanli  3 , A Enes Arikan  2 , Neslihan Cabioglu  4 , Cihan Uras  2
Affiliations
Comparative Study

Comparison of Clinicopathologic Features and Survival Outcomes of Pleomorphic Lobular, Classical Lobular, and Invasive Ductal Carcinoma

Ahmet Necati Sanli et al. World J Surg. 2025 Jun.

Abstract

Purpose: The objective of this research is to assess the clinical importance of pleomorphic lobular carcinoma (PLC) by contrasting its survival outcomes and clinicopathological characteristics with those of classical invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).

Methods: Data from the SEER (Surveillance, Epidemiology, and End Results) database, which covers patients with breast cancer diagnosed between 2010 and 2021, are used in this retrospective analysis. Clinical, pathological, and demographic factors were noted. Kaplan-Meier and Cox regression models were used to conduct survival analyses.

Results: A total of 639,943 patients were included in the study. 182 (0.03%) patients were diagnosed with PLC, 74,565 (11.6%) were with ILC, and 565,196 (88.3%) were with IDC. Compared with ILC and IDC, PLC was associated with higher tumor grade, higher T, N stage, and stage 3-4 AJCC stage, higher hormone negativity, and triple negativity rates. Breast-conserving surgery (BCS) rates were lower in the PLC group, whereas mastectomy, no surgery, and chemotherapy rates were higher. Five-year and 10-year overall survival (OS) and disease-specific survival (DSS) rates were significantly lower in the PLC group than in both ILC and IDC (p < 0.05). However, when survival outcomes were evaluated according to stage, no statistically significant differences in overall survival (OS) or disease-specific survival (DSS) were found between PLC and ILC or between PLC and IDC across all disease stages (p > 0.05).

Conclusion: PLC, a very rare type of breast cancer, has worse clinicopathological features and worse survival outcomes than both ILC and IDC. These findings highlight the need for more specialized personalized targeted therapeutic strategies for PLC.

Keywords: SEER; breast cancer; pleomorphic lobular carcinoma; survival.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. H.‐P. Sinn and H. Kreipe, “A Brief Overview of the WHO Classification of Breast Tumors, 4th Edition, Focusing on Issues and Updates From the 3rd Edition,” Breast Care 8, no. 2 (2013): 149–154, https://doi.org/10.1159/000350774.
    1. WHO Classification of Tumours of the Breast ‐ UQ eSpace [Internet]. [cited 2024 Aug 8]. Available from, https://espace.library.uq.edu.au/view/UQ:8984059
    1. M. Cristofanilli, A. Gonzalez‐Angulo, N. Sneige, et al., “Invasive Lobular Carcinoma Classic Type: Response to Primary Chemotherapy and Survival Outcomes,” J Clin Oncol Off J Am Soc Clin Oncol 23, no. 1 (2005): 41–48, https://doi.org/10.1200/jco.2005.03.111.
    1. J. Rosai, Rosai and Ackerman’s Surgical Pathology E‐Book [Internet] (Elsevier Health Sciences, 2011).
    1. P. P. Rosen, Rosen’s Breast Pathology (Lippincott Williams & Wilkins, 2001).1028

Publication types

LinkOut - more resources